Amyloidosis is a group of conditions characterized by the accumulation of amyloid deposits
in various tissues. Among these disorders, ATTR amyloidosis occurs either with or without a …

Aims Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly diagnosed at an
early stage of the disease natural history, defined as National Amyloidosis Centre (NAC) …

Background: Cardiac amyloidosis had been considered to be an incurable disease;
however, new disease-modifying therapeutic approaches have succeeded in ameliorating …

An earlier healthy 64-year-old man with previous surgery for bilateral carpal tunnel
syndrome (CTS) in his 50s, presented with dyspnoea on exertion. Cardiac amyloidosis was …

Transthyretin amyloidosis (ATTR) is caused by deposition of either wild‐type (ATTRwt) or
variant (ATTRm) transthyretin. ATTRwt presents with restrictive cardiomyopathy, while …

Abstract Purpose of Review The review's main focus centers on the genetics of hereditary
cardiac amyloidosis, highlighting the opportunities and challenges posed by the widespread …

Cardiac amyloidosis of transthyretin fibril protein (ATTR) type is an infiltrative
cardiomyopathy characterised by ventricular wall thickening and diastolic heart failure …

Transthyretin-related hereditary amyloidosis (ATTR) is genotypically/phenotypically
heterogeneous. We investigated myocardial involvement in ATTR in a cohort of patients with …

Aims Transthyretin amyloidosis (ATTR amyloidosis) is a heterogeneous disorder with
cardiac, neurologic, and mixed phenotypes. We describe the phenotypic and genotypic …

Background Hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) is a
multisystem disease that presents with polyneuropathy and/or cardiomyopathy. Methods …